vTv Therapeutics Inc. Class A (VTVT)
NASDAQ: VTVTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 32.71 +5.50%
VTVT stock chart
Technical analysisKey statistics
All statistics- Market cap
- $122.61M
- EPS (TTM)
- -$0.72
- Dividend yield
- None
- 52-week range
- 19.50 – 44.00
- Day range
- 29.86 – 31.50
- Volume / Avg
- 25.81K / 68.59K
- Beta
- —
- Shares outstanding
- 3.95M
- Next earnings
- Nov 5, 2026
52-week range
VTVT stock today
Shares of vTv Therapeutics (VTVT) finished higher on Oct 7 at $31.01, a gain of 3.26% or $0.98 per share, versus the S&P 500's 0.22% decline. Trading was light, with 25.81K shares changing hands, about 38% of the average daily volume. At this level, VTVT sits in the middle of its 52-week range of $19.50 to $44.00: 29.5% below the high, set on Jan 6, 2026 and 59.0% above the low.
VTVT is down 22.5% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 37.5%. vTv Therapeutics has posted a net loss over the last twelve months (EPS of -$0.72), so its P/E ratio is not meaningful. vTv Therapeutics's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About vTv Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2015
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-1.07
VTVT news
All VTVT newsvTv Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| INOInovio Pharmaceuticals Inc. | 1.16 | +2.21% | $119.42M | vs VTVT |
| QUCYQuantum Cyber N.V. | 1.43 | +10.85% | $120.22M | vs VTVT |
| COYACoya Therapeutics Inc. | 4.91 | +1.24% | $115.18M | vs VTVT |
| UNCYUnicycive Therapeutics Inc. | 4.18 | -1.18% | $114.50M | vs VTVT |
| RANIRani Therapeutics Holdings Inc. Class A | 0.8121 | -2.02% | $114.12M | vs VTVT |
| GNLXGenelux Corporation | 2.52 | -0.79% | $114.02M | vs VTVT |
| FHTXFoghorn Therapeutics Inc. | 2.09 | +6.09% | $124.12M | vs VTVT |
| PMVPPMV Pharmaceuticals Inc. | 1.50 | -6.83% | $113.27M | vs VTVT |
Indexes, lists and sector
vTv Therapeutics stock FAQ
What is vTv Therapeutics's stock price today?
VTVT last traded at $31.01 as of Oct 7, 4:00 PM EDT, up 3.26% on the day. Prices are delayed at least 15 minutes.
Does vTv Therapeutics pay a dividend?
No. vTv Therapeutics does not currently pay a regular cash dividend.
When is vTv Therapeutics's next earnings date?
vTv Therapeutics is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-1.07.
Has VTVT ever split its stock?
Yes. The most recent VTVT stock split was a 1-for-40 split on Nov 21, 2023.
What is the VTVT 52-week high?
The 52-week high for VTVT is $44.00 and the 52-week low is $19.50. The stock is currently 29.5% below its high.